Skip to content
healthcare.dev

oxcarbazepine

NDC 70771-1842, oxcarbazepine, tablet, from Zydus Lifesciences Limited.

Product NDC
70771-1842
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211747
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1842 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXCARBAZEPINE150 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
70771-1842-170771184201100 TABLET in 1 BOTTLE (70771-1842-1)
70771-1842-47077118420410 BLISTER PACK in 1 CARTON (70771-1842-4) / 10 TABLET in 1 BLISTER PACK
70771-1842-570771184205500 TABLET in 1 BOTTLE (70771-1842-5)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e23d8a74-b47b-462a-b09c-90bdd58a032e

Use it

Look up 70771-1842 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1842 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1842. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.